Zimmer Biomet Holdings (ZBH) Q2 FY2026 earnings: revenue $2.2 billion, up 4.8% on the year
Zimmer Biomet Holdings, Inc. (ZBH) reported revenue of $2.2 billion for Q2 FY2026, the quarter ended 30 June 2026, up 4.8% on the same quarter a year earlier. Net income was $198 million, up 29.8% on the year, and diluted earnings per share $1.03. The figures are the company's own, from the 10-Q it filed with the SEC on 5 August 2026.
Revenue
$2.2 billion
+4.8% on the year · +4.3% on the quarter
Q3 FY2024Q2 FY2026
Operating margin
15.0%
14.4% a year earlier
Q3 FY2024Q2 FY2026
Net income
$198 million
+29.8% on the year · -16.7% on the quarter
Q3 FY2024Q2 FY2026
Diluted EPS
$1.03
+33.8% on the year · -15.6% on the quarter
Q3 FY2024Q2 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 6 raised, 1 kept.
Sales rose 4.8% in the quarter: Net sales were $2.177 billion, up 4.8% reported, 4.7% constant currency and 4.0% organic constant currency, from $2,077.3 million a year earlier.
Adjusted EPS flat, reported EPS higher: Diluted EPS was $1.03, up 33.8% from $0.77. Adjusted diluted EPS was $2.07, consistent with the prior year period. Adjusted net earnings were $399.6 million.
Reported revenue range raised: The 2026 reported revenue change range moved to 3.9% to 4.9%, from 2.5% to 4.5%. Management cited the first-half results, underlying markets and go-to-market progress.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
448
359
378
+24.6%
+18.4%
Capital expenditure
54.2
36.3
50.1
+49.3%
+8.2%
Free cash flow
394
323
328
+21.8%
+20.0%
Free cash flow margin
18.1%
15.5%
15.8%
Cash from investing
-191
-159
-1,384
Cash from financing
-271
-369
164
Depreciation and amortisation
271
270
272
+0.3%
-0.4%
Share-based compensation
24.6
24.2
21.2
+1.7%
+16.0%
Buybacks
251
250
7.2
+0.2%
+3,381.9%
Dividends paid
46.5
46.9
47.5
-0.9%
-2.1%
Dividend per share
$0.24
$0.24
$0.24
0.0%
0.0%
Diluted shares, weighted
193m
196m
198m
-1.5%
-2.8%
Shares outstanding at period end
191m
193m
198m
-1.4%
-3.7%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
12,624
12,673
12,525
-0.4%
+0.8%
Non-controlling interest
8.7
8.2
9.3
+6.1%
-6.5%
Debt
7,479
7,471
7,572
+0.1%
-1.2%
Other liabilities
2,686
2,569
2,758
+4.6%
-2.6%
Total liabilities and equity
22,798
22,722
22,865
+0.3%
-0.3%
Fixed assets
2,237
2,212
2,176
+1.1%
+2.8%
Goodwill
9,920
9,932
9,710
-0.1%
+2.2%
Intangible assets
4,462
4,548
4,891
-1.9%
-8.8%
Cash and equivalents
410
424
557
-3.3%
-26.4%
Receivables
1,770
1,729
1,611
+2.4%
+9.8%
Inventory
2,270
2,247
2,454
+1.0%
-7.5%
Other assets
1,730
1,631
1,467
+6.1%
+18.0%
Total assets
22,798
22,722
22,865
+0.3%
-0.3%
Questions
What was Zimmer Biomet Holdings' revenue in Q2 FY2026?
Zimmer Biomet Holdings (ZBH) reported revenue of $2.2 billion for Q2 FY2026, the quarter ended 30 June 2026, up 4.8% on the same quarter a year earlier.
How much did Zimmer Biomet Holdings earn in Q2 FY2026?
Net income for Q2 FY2026 was $198 million, up 29.8% on the year, and diluted earnings per share $1.03.
When did Zimmer Biomet Holdings report Q2 FY2026 results?
Zimmer Biomet Holdings filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 5 August 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 June 2026, filed 5 August 2026: the filing.